VW
Vikas Wahi
About Vikas Wahi
Data last updated:
Vikas Wahi has 14 years in corporate governance. Holds Director role. Currently with 3 companies, including Safeguard Lifesciences Private Limited and Kraepelin Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Safeguard Lifesciences Private Limited at ₹4.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Oct 2012 | 2012 | ₹4.34 Cr (FY 2025) | Active | |
| Director | 24 Apr 2025 | 2025 | – | Active | |
| Director | 27 May 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vikas Wahi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikas Wahi
Vikas Wahi has 14 years in corporate governance. Holds Director role. Currently with 3 companies, including Safeguard Lifesciences Private Limited and Kraepelin Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Safeguard Lifesciences Private Limited at ₹4.34 Cr (FY 2025).
Vikas Wahi is associated with 3 companies as Director, including Safeguard Lifesciences Private Limited (₹4.34 Cr), Curevia Wellness Private Limited, Kraepelin Pharmaceuticals Private Limited.
Vikas Wahi has expertise in General Business.
Vikas Wahi has 14 years in corporate governance.
By reported revenue, the largest current company of Vikas Wahi is Safeguard Lifesciences Private Limited, with revenue of ₹4.34 Cr (FY 2025).
Vikas Wahi currently holds positions at 3 companies: Safeguard Lifesciences Private Limited (₹4.34 Cr), Curevia Wellness Private Limited, Kraepelin Pharmaceuticals Private Limited.